UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Clinical assessment of wounds

Authors
David G Armstrong, DPM, MD, PhD
Andrew J Meyr, DPM
Section Editors
Hilary Sanfey, MD
John F Eidt, MD
Joseph L Mills, Sr, MD
Russell S Berman, MD
Deputy Editor
Kathryn A Collins, MD, PhD, FACS

INTRODUCTION

A wound represents a disruption of the normal structure and function of the skin and soft tissue structure and may be due to a variety of mechanisms and etiologies [1]. The clinical assessment of wounds begins with a determination of whether the wound is acute or chronic in nature. Acute wounds are those in which healing is anticipated to progress through an orderly physiologic sequence of inflammation, proliferation and maturation [2,3]. A chronic wound may be defined as one that is physiologically impaired because of inadequate angiogenesis, impaired innervation, or impaired cellular migration among other reasons [4]. Examples of chronic wounds include ischemic ulcers, venous ulcers, diabetic foot ulcers and infected wounds including surgical site infections [5,6].

The clinical assessment of acute and chronic wounds, including differentiating the most common chronic ulcers, will be reviewed. Treatment of chronic wounds is discussed separately.

(See "Basic principles of wound management".)

(See "Overview of treatment of chronic wounds".)

(See "Management of diabetic foot ulcers".)

             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Feb 18 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 2002; 3:179.
  2. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003; 11 Suppl 1:S1.
  3. Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006; 117:12S.
  4. Golinko MS, Clark S, Rennert R, et al. Wound emergencies: the importance of assessment, documentation, and early treatment using a wound electronic medical record. Ostomy Wound Manage 2009; 55:54.
  5. Brem H, Balledux J, Bloom T, et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg 2000; 135:627.
  6. Brem H, Jacobs T, Vileikyte L, et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Int 2003; 11:85.
  7. Rennert R, Golinko M, Kaplan D, et al. Standardization of wound photography using the Wound Electronic Medical Record. Adv Skin Wound Care 2009; 22:32.
  8. Sheehan P, Jones P, Giurini JM, et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg 2006; 117:239S.
  9. Lavery LA, Barnes SA, Keith MS, et al. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care 2008; 31:26.
  10. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54:e132.
  11. Lipsky BA, International consensus group on diagnosing and treating the infected diabetic foot. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004; 20 Suppl 1:S68.
  12. Armstrong DG, Lipsky BA. Diabetic foot infections: stepwise medical and surgical management. Int Wound J 2004; 1:123.
  13. Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther 2004; 6:167.
  14. Lazarides MK, Giannoukas AD. The role of hemodynamic measurements in the management of venous and ischemic ulcers. Int J Low Extrem Wounds 2007; 6:254.
  15. Porter, RK. The Merck Manual, Merck Sharp & Dohme Corp.
  16. Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014; 59:220.
  17. Armstrong DG, Mills JL. Juggling risk to reduce amputations: The three-ring circus of infection, ischemia and tissue loss-dominant conditions. Wound Medicine 2013; 1:13.
  18. O'Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008; :CD003557.
  19. Atugoda S, Audring H, Voit C, et al. Chronic indurated ulceration of the leg, epithelioid sarcoma with lymph node metastasis. Eur J Dermatol 2003; 13:599.
  20. Kofler H, Pichler E, Romani N, et al. Hemangiosarcoma in chronic leg ulcer. Arch Dermatol 1988; 124:1080.
  21. Berth-Jones J, Fletcher A, Graham-Brown R. Cutaneous malignant fibrous histiocytoma. A rare but serious malignancy. Acta Derm Venereol 1990; 70:254.
  22. Senet P, Combemale P, Debure C, et al. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study. Arch Dermatol 2012; 148:704.
  23. Martorell F. Hypertensive ulcer of the leg. J Cardiovasc Surg (Torino) 1978; 19:599.
  24. Shelling ML, Federman DG, Kirsner RS. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers. Arch Dermatol 2010; 146:1026.
  25. Hafner J, Nobbe S, Partsch H, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol 2010; 146:961.
  26. Senet P, Vicaut E, Beneton N, et al. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol 2011; 147:926.